Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The European School of Haematology (ESH) International Conference on Multiple Myeloma 2018 was held in Mandelieu, France, from October 5–7th.
Explore the current trends and clinical updates, including expert opinion on recent FDA and EMA approvals, trial updates, early intervention and screening at the smoldering stage, and vaccine and CAR T-cell therapy.
ESH MM 2018
The European School of Haematology (ESH) International Conference on Multiple Myeloma 2018 was held in Mandelieu, France, from October 5–7th.
Explore the current trends and clinical updates, including expert opinion on recent FDA and EMA approvals, trial updates, early intervention and screening at the smoldering stage, and vaccine and CAR T-cell therapy.
